Perfluorooctane sulfonic acid (PFOS)

PFOS is one of the so-called forever chemicals, and once it gets into your body from food, water, or everyday products, it can stay there for years. Knowing your exposure matters because higher levels have been tied to higher cholesterol, a weaker response to vaccines, liver strain, and problems in pregnancy.

There is one thing worth knowing before you read your result. Urine is a weak window into PFOS, because this chemical is cleared very poorly through urine and is far easier to detect in blood.

What PFOS Actually Is

PFOS (perfluorooctane sulfonic acid) is a synthetic chemical built around a chain of carbon atoms wrapped in fluorine, which makes it extraordinarily stable. It does not occur in nature, your body does not make it, and your body cannot break it down.

You are exposed through contaminated drinking water, food, household dust, and consumer products, not through any internal process. Because it resists breakdown, it is regulated worldwide as a persistent pollutant, and a urine test simply captures a small amount your body is trying to clear.

Why Urine Is a Weak Window

This is the single most important thing to understand about a urine PFOS result. In a large U.S. survey that measured both blood and urine, PFOS was detected in the blood of essentially everyone but showed up in fewer than 0.1 percent of urine samples. In children studied in Spain, urinary PFOS appeared in only 3.2 percent of samples, all below 1 nanogram per milliliter.

The gap between the two is dramatic. In one paired sample, a blood PFOS level of 1,270 micrograms per liter corresponded to just 0.6 micrograms per liter in urine, more than a thousandfold lower. PFOS leaves the body mainly through stool rather than urine, with fecal output running roughly four times higher than urinary output in a highly exposed community.

Here is how to hold both facts at once without contradiction. A low or undetectable urine PFOS does not mean your body burden is low, because urine is simply not where this chemical concentrates. This is not a reassuring green light the way a normal cholesterol number might be. It is a rough exposure signal, and blood remains the reference matrix that captures the real body burden.

Cholesterol and Heart Health

The most consistent human finding for PFOS is a link to higher cholesterol. Multiple pooled analyses of blood-based studies (which measure serum PFOS rather than urine) found that people with higher PFOS tended to have higher total and LDL cholesterol, the fraction most tied to heart disease. Reviews describe abnormal blood lipids as the strongest metabolic signal associated with PFOS exposure.

In adolescents, those in the highest quarter of PFOS exposure had nearly twice the odds of high blood pressure compared with the lowest quarter (odds ratio 1.86). Broader reviews connect PFOS to cardiovascular risk through effects on oxidative stress (cell and tissue damage from unstable, reactive molecules) and how the body handles blood fats, though these come from serum studies, not urine.

Immune Function

A major scientific review concluded that the human evidence for PFAS suppressing the immune system is strong. Children exposed to PFOS before birth had more clinician-recorded infections, and related work links PFAS to weaker antibody responses. One small case-control study found urinary PFOS associated with about twice the odds of testing positive for COVID-19 (adjusted odds ratio 1.94), but that is preliminary and needs larger confirmation.

Liver Strain

Higher PFOS is associated with higher ALT, an enzyme that rises when liver cells are stressed or injured, in pooled human studies (again measured in serum, not urine). Reviews describe consistent signals of liver involvement, which fits laboratory work linking PFOS to disrupted fat and bile-acid handling in the liver.

Kidney Function

Kidney evidence is real but mixed. In a large U.S. survey, higher serum PFOS was associated with slightly lower filtration rate, a measure of how well the kidneys clean the blood. A prospective cohort found that the branched form of PFOS, rather than total PFOS, predicted faster kidney decline over four years, while one Chinese cohort unexpectedly linked PFOS to lower odds of chronic kidney disease.

Part of this messiness is mechanical. Kidney function itself shapes how much PFOS you excrete, so damaged kidneys can shift the numbers in ways that make cause and effect hard to untangle. Higher PFOS has also been tied fairly consistently to higher uric acid, a driver of gout and a marker often watched alongside kidney health.

Pregnancy and Birth Outcomes

Pregnancy carries the clearest human outcome signal. A meta-analysis found higher PFOS during pregnancy associated with a modestly increased risk of preterm birth and with preeclampsia (about 27 percent higher odds per log increase). A cohort study linked higher serum PFOS to pregnancy-induced high blood pressure (roughly 47 percent higher odds per log increase) and to slightly lower birth weight in full-term infants.

During pregnancy, PFOS was also tied to higher markers of oxidative stress (cell damage from unstable, reactive molecules), a plausible route to these outcomes. These findings are why people who are pregnant or planning to conceive often have the most to gain from understanding their exposure.

Tracking Your Trend

Because PFOS leaves the body slowly, a single number tells you less than a trajectory does. Human studies estimate PFOS takes roughly 3 to 5 years to fall by half after exposure stops, so change happens over years, not weeks. That slow clock is exactly why tracking matters: it is the only way to see whether cutting an exposure source is actually moving your burden down.

A reasonable rhythm is a baseline now, then a repeat after you remove a suspected source, and at least annual checks thereafter. One caution specific to this test: because PFOS is so rarely detectable in urine, urine trends are noisy. If you are serious about tracking whether an intervention is working, a blood-based PFAS measurement will show change far more reliably than urine will.

What an Unexpected Result Should Prompt

If PFOS is detectable in your urine, or if you have strong reason to suspect exposure despite a low urine result, the most useful next step is a serum PFAS panel, since blood is the matrix that actually reflects body burden. Pair that with an honest exposure review: your drinking water source, your occupation, and where you live relative to airports, military sites, or industrial facilities.

From there, the actionable follow-up is on the downstream systems PFOS affects. Consider checking a lipid panel, liver enzymes such as ALT, kidney filtration, and uric acid, and interpret them as a pattern rather than any single value. If you are pregnant or planning pregnancy, or if you carry a heavy suspected exposure, an environmental health or toxicology specialist can help you weigh the picture.

When a Single Reading Can Mislead

• Wrong matrix for the job: because PFOS concentrates in blood, not urine, a low urine value can sit alongside a meaningful blood level. This is the biggest source of false reassurance with this test.
• Kidney function: how well your kidneys filter and reabsorb affects how much PFOS reaches your urine, so kidney disease can shift the number independent of your true exposure.
• Dilution and hydration: urine concentration varies with how much you drink, which is why labs often adjust to creatinine to compare samples fairly.
• Isomer differences: branched and linear forms of PFOS leave the body at different rates, so two people with similar exposure can show different urine patterns.